Reblozyl (luspatercept)

pCPA File Number: 21686
Negotiation Status:
Concluded with an LOI
Indication(s):
myelodysplastic syndromes associated anemia
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0670
pCPA Engagement Letter Issued:
Negotiation Process Concluded: